- Correction
- Open access
- Published:
Correction: Combination chemotherapy of valproic acid (VPA) and gemcitabine regulates STAT3/Bmi1 pathway to differentially potentiate the motility of pancreatic cancer cells
Cell & Bioscience volume 13, Article number: 206 (2023)
The Original Article was published on 18 June 2019
Correction: Cell Biosci (2019) 9:50 https://doi.org/10.1186/s13578-019-0312-0
In the original publication of the article [1], the authors have noticed that a number of image files were inadvertently used or misplaced in Figs. 4 and 5 panels, likely due to processing a large number of migration or invasion transwell images in the original data folder.
Specifically, in Fig. 4c there were two images incorrectly used to represent the migration of patu8988 cells in group GEM + VPA (0.5 mM) (2nd row, 2nd column), and the invasion of PANC-1 cell in group GEM + VPA (0.5 mM) + S3I-201 (3rd row, 3rd column). In Fig. 5d, one image was used incorrectly to represent the invasion of PANC-1 cell in group GEM + VPA (0.5 mM) + NAC (3rd row, 3rd column).
The corrected figures (Fig. 4c and Fig. 5d) are given below.
Reference
Li H, Zhang Z, Gao C, Wu S, Duan Q, Wu H, Wang C, Shen Q, Yin T. Combination chemotherapy of valproic acid (VPA) and gemcitabine regulates STAT3/Bmi1 pathway to differentially potentiate the motility of pancreatic cancer cells. Cell Biosci. 2019;9:50. https://doi.org/10.1186/s13578-019-0312-0.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Li, H., Zhang, Z., Gao, C. et al. Correction: Combination chemotherapy of valproic acid (VPA) and gemcitabine regulates STAT3/Bmi1 pathway to differentially potentiate the motility of pancreatic cancer cells. Cell Biosci 13, 206 (2023). https://doi.org/10.1186/s13578-023-01155-8
Accepted:
Published:
DOI: https://doi.org/10.1186/s13578-023-01155-8